BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 1, 2014
View Archived Issues
Teijin signs agreement with Sigma-Tau for Japanese development of EZN-2279
Read More
Revive Therapeutics reports phase IIa results for REV-001
Read More
First-in-human results presented on nesvacumab for advanced cancers
Read More
RG-7388, an oncoprotein Mdm2 antagonist, evaluated in phase I trial
Read More
Novel STAT3 inhibitors presented by Otsuka Pharmaceutical
Read More
Prosensa receives research grant from Parent Project Muscular Dystrophy
Read More
Sirukumab shows a negative risk/benefit profile for active lupus nephritis
Read More
Novel chimeric fusion protein reduces arthritis in a mouse model
Read More
EMA committee hands down positive opinion on Eylea for DME
Read More
Dompe's treatment for ocular disease obtains FDA orphan drug status
Read More
Bevacizumab recommended for E.U. approval in new indication
Read More
Debiopharm and Nobelex collaborate on antibiotics against N. gonorrhoeae and enteric species
Read More
Desmoteplase does not meet primary endpoint in phase III DIAS-3 trial
Read More
Merck KGaA and CRT describe novel Wnt signaling inhibitors
Read More
VenatoRx prepares new beta-lactamase inhibitors for bacterial infections
Read More
EMA committee recommends approval of Triumeq
Read More
New PDE4 inhibitors and M3 antagonists disclosed by Chiesi Farmaceutici
Read More
CHMP recommends Velphoro for control of serum phosphorus levels in adults with CKD
Read More
Roche patents novel CB2 receptor agonists
Read More
ChemoCentryx describes new CCR1 receptor antagonists
Read More
Genervon reports biomarker data from phase IIa GALS-001 trial in ALS
Read More
RedHill Biopharma acquires Mesupron from Wilex
Read More
InDex Pharmaceuticals discloses clinical data for TLR9 agonist in ulcerative colitis
Read More
GSK and Genmab report topline results from a phase III study of ofatumumab
Read More
EMA accepts for review Merck & Co.'s MAA for anti-PD-1 MAb pembrolizumab
Read More
GSK and Theravance submit sNDA for fluticasone furoate/vilanterol
Read More
Kyowa Hakko Kirin resubmits additional indication application for mogamulizumab
Read More